Chronic obstructive pulmonary disease and comorbidities

M Decramer, W Janssens - The Lancet Respiratory Medicine, 2013 - thelancet.com
Results of epidemiological studies have shown that chronic obstructive pulmonary disease
(COPD) is frequently associated with comorbidities, the most serious and prevalent being …

An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease

BR Celli, M Decramer, JA Wedzicha… - American journal of …, 2015 - atsjournals.org
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of
morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic …

Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer

PT King - Clinical and translational medicine, 2015 - Springer
Chronic obstructive pulmonary disease (COPD) is characterized by lung inflammation that
persists after smoking cessation. This inflammation is heterogeneous but the key …

Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease

JA Wedzicha, SE Brill, JP Allinson, GC Donaldson - BMC medicine, 2013 - Springer
Exacerbations of chronic obstructive pulmonary disease (COPD) are important events that
carry significant consequences for patients. Some patients experience frequent …

Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications

H Qureshi, A Sharafkhaneh… - … advances in chronic …, 2014 - journals.sagepub.com
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide and results in an economic and social burden that is both substantial and …

Time‐related biases in pharmacoepidemiology

S Suissa, S Dell'Aniello - Pharmacoepidemiology and drug …, 2020 - Wiley Online Library
Purpose Observational studies using computerized healthcare databases have become
popular to investigate the potential effectiveness of old drugs for new indications. Many of …

Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease

B Yeganeh, E Wiechec, SR Ande, P Sharma… - Pharmacology & …, 2014 - Elsevier
The cholesterol biosynthesis pathway, also known as the mevalonate (MVA) pathway, is an
essential cellular pathway that is involved in diverse cell functions. The enzyme 3-hydroxy-3 …

Comorbidities and systemic effects of chronic obstructive pulmonary disease

G Choudhury, R Rabinovich… - Clinics in chest …, 2014 - chestmed.theclinics.com
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide. It has been projected to move from the sixth to the third most common cause of …

Pharmacological actions of statins: potential utility in COPD

RP Young, R Hopkins, TE Eaton - European Respiratory …, 2009 - publications.ersnet.org
Chronic obstructive pulmonary disease (COPD) is characterised by minimally reversible
airflow limitation and features of systemic inflammation. Current therapies for COPD have …

Statins, systemic inflammation and risk of death in COPD: the Rotterdam study

L Lahousse, DW Loth, GF Joos, A Hofman… - Pulmonary …, 2013 - Elsevier
BACKGROUND: Studies suggest that statins decrease mortality in COPD patients but it is
unknown which patients might benefit most. OBJECTIVES: We investigated whether statins …